Skip to main content

Table 4 Summary of prior findings regarding factors associated with non-alcoholic fatty pancreas

From: Association between non-alcoholic fatty pancreatic disease (nafpd) and the metabolic syndrome: case–control retrospective study

Study

Sample size (FP:NP)

Method of detection

Associated factors

No correlation

Al-Haddad M, et al.[11]

120 (60/60)

EUS

BMI, hepatic steatosis, alcohol

 

Sepe PS, et al.[10]

230 (64/166)

EUS

BMI, fatty liver, hyperlipidemia, MetS

DM, pancreatits, pancreatic cancer, age, alcohol, tobacco amylase

Choi CW, et al.[17].

284 (174/110)

EUS

Hepatic steatosis, HTN, Alcohol, tobacco male, age>60

 

Lee JS, et al.[13]

293 (180/113)

Trans-abd ominal US

IR, VAT, ALT, MetS

FBG, LDL-C

Heni M et al.[12]

51

MRI

BMI, VAT, waist circumference

Fatty liver

Lingvay I, et al. [14]

79

MRI

BMI, hyperglycemia

 

Sijens PE, et al.[15]

36

MRI

BMI, liver fat

 

Tushuizen ME, et al.[16]

36 (12/24)

MRI

Beta-cell dysfunction

Fatty liver, VAT

  1. IR, insulin resistance; DM, diabetes mellitus; MetS, metabolic syndrome; ALT, alanine aminotransferase; HTN, hypertension; VAT, visceral adipose tissue; FP, fatty pancreas; NP, normal pancreas; EUS, endoscopic ultrasonography; US, ultrasonography; FBG, fasting blood glucose; LDL-C, low density lipoprotein-cholesterol.